Upcoming Presentations

UBC scientists participate in scientific and clinical meetings around the world. To learn more about a presentation, please contact the UBC scientist directly or call 301-654-9729.

  • SCOPE Summit for Clinical Ops Executives

    Feb 7 - Feb 9 2012
    Miami, FL, USA
    www.scopesummit.com/


    PRE-CONFERENCE SHORT COURSE
    Social Media and Mobile Technology in Supporting Patients in Studies and Registries
    Abbe Steel, Vice President, Patient & Physician Services, United BioSource Corporation

    SESSIONS
    Customized Targeting and Profiling: Finding the Right Patient in the Right Way
    Nancy Mulligan, Director Patient & Physician Services, United BioSource Corporation

    Is There Patient Recruitment in a Post-Marketing Study?
    Tess Dorrier, Associate Director, Patient & Physician Services, United BioSource Corporation

    TRIAL SPONSOR PANEL
    Find the Ideal Site
    Moderator: Abbe Steel, Vice President, Patient & Physician Services, United BioSource Corp.
    Panelists: Joseph Kim, MBA, Clinical Operations Director, Shire; Nye Pelton, (COPM) Clinical Operations Portfolio Management, USMD, Eli Lilly; Sudeesh Tantry, PhD, Associate Director, Clinical Research, Teva Branded Pharmaceutical Products R&D, Inc.

    ROUNDTABLES
    TABLE 18:     Keeping Post Marketing Studies Top of Mind
    Moderator: Tess Dorrier, Associate Director, Patient & Physician Services, United BioSource Corp.

    TABLE 32: Recruiting using a Social Marketing Approach
    Moderator: Nancy Mulligan, Director, Patient & Physician Services, United BioSource Corp.

  • 13th Annual CTS Europe

    Feb 21 - Feb 22 2012
    London, UK
    www.arena-international.com/ctseurope

    SPEAKER
    Optimising the Accuracy and Efficiency of Demand Forecasting Through Effective Use of Your IVRS
    Kimberly Sierk, Senior Design Engineer, Bracket

  • ISCTM 8th Annual Scientific Meeting

    Feb 21 - Feb 23 2012
    Washington, DC, USA
    www.cvent.com/events/8th-annual-scientific-meeting-plus-forum/event-summary-bd23243ecc7d4ffba95dde9551922b4d.aspx

    SESSION SPEAKER
    Defining Clinically Meaningful Effect for the Design and Interpretation of RCTs - Payers Perspectives
    Robert S. Epstein, MD, MS, Senior Vice President and Chief Medical Officer, Medco Health Solutions and President, United BioSource Corporation 

    WORKSHOPS
    Negative Symptoms
    Co-Chairs: Stephen Marder, MD, Director, Dept. of Veterans Affairs and Prof. Psychiatry, UCLA; David Daniel, MD, Senior Vice President, Chief Medical Director, Bracket

    Suicidal Ideation and Behavior Assessment
    Co-Chairs: Adam Butler, Associate VP, Marketing & Customer Services, Bracket; Michelle Stewart, PhD, Director, Pfizer

    POSTER PRESENTATIONS
    Assessing Cognitive Function Via The Internet
    Wesnes K

    Assessing Longitudinal Changes In Cognitive Function In The Elderly
    Wesnes K

    Low-Contrast Visual Acuity Correlates with Cognitive Performance in Relapsing-Remitting and Secondary-Progressive Multiple Sclerosis
    Feaster T

    Novel Method for Maintaining Ratings Quality in Global Schizophrenia Clinical Trials
    Daniel D, Kott A

    Ratings Variability of UPDRS Part III Sub-items in Multinational Parkinson’s Disease Clinical Trials
    Swartz J, Wesnes K

  • CBI's 8th Annual Summit on Late Phase Research

    Feb 28 - Feb 29 2012
    Amsterdam, Netherlands
    www.cbinet.com/conference/pc12011

    SPEAKER
    Transparency of Benefit-Risk Analysis in Drug Development - An EMA Initiative
    Ruben Ayzin Rosoky, MD, PhD, Safety Physician, United BioSource Corporation

  • SUFU Society for Urodynamics and Female Urology 2010 Winter Meeting

    Feb 28 - Mar 3 2012
    New Orleans, LA, USA
    www.sufuorg.com/meetings/2012/default.aspx

    PODIUM PRESENTATIONS
    Short-Term Outcomes of Vaginal Mesh Placement Among Female Medicare Beneficiaries
    Anger J, Eilber K, Khan A, Histed S, Wu N, Pashos C, Clemens JQ

    Predictors of Outcomes of Prolapse Surgery Among Female Medicare Beneficiaries: The Role of Apical Support
    Histed S, Khan A, Alperin M, Wu N, Pashos C, Clemens JQ, Anger J

    Cost-Effectiveness of Sacral Neuromodulation and Botulinum Toxin-A for Patients with Refractory Idiopathic Overactive Bladder
    Clemens JQ, Anger JT, Ganz ML, Denevich S, Shah D, Carlson AM, Wittek MR, Pashos CL

    Comparative Outcomes of Open Versus Laparoscopic Sacrocolpopexy Among Female Medicare Beneficiaries.
    Prize Essay Winner
    Anger J, Khan A, Alperin M, Wu N, Clemens JQ, Dubina E, Pashos C


    POSTER PRESENTATIONS
    Patterns of Pessary Care Among Medicare Beneficiaries with Pelvic Organ Prolapse
    Khan A, Alperin M, Dubina E, Tarnay C, Wu N, Pashos C, Anger J

    Trends in Prolapse Management Among Medicare Beneficiaries in the New Millennium
    Khan A, Eilber K, Alperin M, Wu N, Clemens JQ, Pashos C, Anger J

    Surgeon Impact on Prolapse Surgery Outcomes
    Eilber K, Khan A, Alperin M, Clemens JQ, Wu N, Pashos C, Anger J

  • Partnerships in Clinical Trials

    Mar 4 - Mar 7 2012
    Orlando, FL, USA
    www.iirusa.com/cropartners/welcome-to-CROs.xml

    PODCAST
    Podcast Interview with Rob Epstein, UBC President, on the Payer Perspective in the Clinical Trial Process


    SESSION PRESENTATION
    Strategic Study Designs that Consider Complex Regulatory and Payer Requirements to Drive Efficiencies and Ensure Successful Product Commercialization
    Presenters: Krista A. Payne, MEd, Senior Director & Senior Research Scientist, United BioSource Corporation; Mary Rose Keller, Vice President of Clinical Operations, Sangart

  • APhA2012 Annual Meeting & Exposition

    Mar 9 - Mar 12 2012
    New Orleans, LA, USA
    www.aphameeting.org/

    POSTER PRESENTATION
    Discontinuation of Warfarin Treatment for Venous Thromboembolism and its Association with Recurrent Events in High-Risk Patients
    Chen SY, Wu N, Gulseth M, LaMori J, Bookhart B, Boulanger L, Fields L, Schein J

  • CBI's Forum on Real-World Data Analytics and Outcomes

    Mar 14 - Mar 15 2012
    Philadelphia, PA, USA
    www.cbinet.com/conference/pc12002

    SPEAKER
    Increase Efficiency When Gathering Real-World Data through Strategic Registry Designs and Operational Infrastructures
    Krista A. Payne, Executive Director & Senior Research Scientist, United BioSource Corporation

  • Comparative Effectiveness: A Real-World User's Guide

    Mar 14 - Mar 15 2012
    Washington, DC, USA
    meetings.diahome.org/12027/#overview

    SESSION SPEAKER
    Comparative Effectiveness Policy Background, Perspectives and Issues
    Bryan R. Luce, PhD, MBA, Senior Vice President, Science Policy, United BioSource Corporation

  • Pharma Pricing & Market Access Outlook Europe

    Mar 20 - Mar 23 2012
    London, UK
    www.healthnetworkcommunications.com/conference/pharma-pricing-market-access/

    SPEAKER
    Get Over It: Embrace Payer Expectations by Introducing Them Early in Product Development
    Raf De Wilde, PhD, Associate Vice President, Global Market Access Consulting, United BioSource Corporation

  • Late Phase Drug Development World Americas

    Mar 20 - Mar 23 2012
    Boston, MA, USA
    www.healthnetworkcommunications.com/2012/late-phase-drug-development/

    SPEAKER
    Getting the Right Evidence From Your Late Stage Activities: The Importance of Planning Ahead
    Teresa (Terry) K. Wilcox, RPh, PhD, Senior Research Scientist, Evidence Generation Strategy Practice Lead, United BioSource Corporation

  • ACC.12 American College of Cardiology 61st Annual Scientific Session & Expo

    Mar 24 - Mar 27 2012
    Chicago, IL, USA
    accscientificsession.cardiosource.org/ACC12.aspx

    POSTER PRESENTATION
    Incidence Rates of Death and Major Cardiovascular Events among Hospitalized Patients with Acute Coronary Syndrome – An Analysis of a National Representative Medicare Population
    Crivera C, Chen SY, Stokes M, Boulanger L, Schein J

  • DIA 24th Annual EuroMeeting

    Mar 26 - Mar 28 2012
    Copenhagen, Denmark
    www.diahome.org/diahome/FlagshipMeetings/home.aspx?meetingid=25205

    SESSION 0403
    Tues., 27 March 2012, 14:00 - 15:30

    Update on How Agencies and Patients Assess the Therapeutic Value and Therapeutic Added Value of Medicines: How Does this Impact the HTA Processes?
    Theme Leader and Session Chair: Ingela Wiklund, PhD, Senior Research Leader, United BioSource Corp.

    SESSION 0407
    Wed., 28 March 2012, 14:00 - 15:30

    A Case Study - How to Make the Most of Your Observational Data
    Speaker: Krista Payne, MEd, Senior Director of Healthcare Data Capture, Senior Research Scientist, United BioSource Corp.

    SESSION 1008
    Wed., 28 March 2012, 16:00 - 17:30

    The Perfect e-Menu (Meeting the Needs of Lifecycle Research)
    Speaker: Rob Thwaites, MA, MCom, Vice President Health Economics, United BioSource Corp.

  • World Drug Safety Congress Americas

    Apr 17 - Apr 20 2012
    Boston, MA, USA
    www.healthnetworkcommunications.com/2012/world-drug-safety-congress/

    SPEAKER
    Benefit Risk Analysis: Responding to the New Regulatory Framework
    Jonathan Morris, MD, Vice President, Evidence Development, United BioSource Corporation

  • AMCP 24th Annual Meeting & Expo

    Apr 18 - Apr 20 2012
    San Francisco, CA, USA
    www.amcpmeetings.org/

    POSTER PRESENTATIONS
    Compliance With Warfarin Treatment for Venous Thromboembolism in High-Risk Patients and Its Association With Recurrent Events
    Chen, SY, Wu N, Gulseth M, Bookhart B, Boulanger L, Fields LE, Schein J, LaMori J

    Impact of a Tier Reduction on Statin Adherence
    Chen, S, Shah SN, Raskind J, Lee Y, Boulanger L, Barus T, Mardekian J, Kuznik A

  • 2012 Eighth Annual Armada Specialty Pharmacy Summit

    May 1 - May 4 2012
    Las Vegas, NV, USA
    www.armadasummit.com/index.html

    SESSION SPEAKER
    Tues., May 1, 2012, 4:30 - 5:30 p.m.

    REMS 2012 and Beyond: Ensuring Your Risk Evaluation and Mitigation Strategy (REMS) Optimizes Appropriate Patient Support
    Annette Stemhagen, DrPH, FISPE, Senior Vice President, Safety, Epidemiology, Registries & Risk Management, United BioSource Corp.

  • ARVO 2012

    May 6 - May 10 2012
    Fort Lauderdale, FL, USA
    www.arvo.org/sites/annual-meeting/2012

    POSTER PRESENTATION
    Vision-Related Symptoms And Functional Impairments In Patients With Geographic Atrophy (GA): Findings From A Qualitative Study
    Wang F, Hareendran A, Sunness JS, Fletcher DC

  • CBI's 9th Forum on Patient Reported Outcomes (PRO)

    May 7 - May 8 2012
    Philadelphia, PA, USA
    www.cbinet.com/conference/pc12141

    SPEAKERS
    Mixed Modes and the Impact on PRO Data Collection
    Sonya Eremenco, ePRO Manager, United BioSource Corporation

    Rasch Analysis to Ensure Quality Questions
    Wen-Hung Chen, PhD, Research Scientist, Outcomes Research, United BioSource Corporation

  • ATS 2012

    May 18 - May 23 2012
    San Francisco, CA, USA
    conference.thoracic.org/2012/index.php

    POSTER PRESENTATIONS
    Conceptualization Of Symptoms And Symptom Impacts Among Adults With Inadequately Controlled Moderate-Severe Asthma
    McLaurin KK, Pokrzywinski R, O'Quinn S, Xu X, Hareendran A

    COPD Patients’ Experience Of Early Morning Symptoms: Results From Qualitative Research
    Mocarski M, Houghton K, Palsgrove A, Hareendran A, Schaefer M, Carson R, Setyawan J, Make BJ

  • DIA 2012 48th Annual Meeting

    Jun 24 - Jun 28 2012
    Philadelphia, PA, USA
    www.diahome.org/DIAHome/Home.aspx

    Mon., June 25, 1:30 - 3:30 p.m.

    SESSION SPEAKER
    A Writer's Perspective on Safety Documents Before the Marketing Application
    Michael D. Hoffman, MS, Senior Director, Medical Writing and Regulatory Operations, United BioSource Corporation

    Mon., June 25, 3:30 - 5:00 p.m.

    SESSION SPEAKERS
    PRO Consortia: A Success Story
    Nancy Kline Leidy, PhD, Senior Vice President, Scientific Affairs, United BioSource Corporation

    Epidemiologic Studies as Part of Risk Management Strategies for Marketed Products
    Catherine Sigler, DVM, MPH, Senior Epidemiologist, United BioSource Corporation

    Tues., June 26, 10:00 - 11:30 a.m.

    SESSION PANELIST
    Collaborative Research with Members of the Payer Community
    Robert S. Epstein, MD, MS, Senior Vice President and Chief Medical Officer, Medco Health Solutions and President, United BioSource Corporation

    Tues., June 26, 12:00 - 1:30 p.m.

    SESSION PANELIST
    Challenges of Precision Medicine: Diagnostics, Reimbursement, Partnership Co-Development
    Robert S. Epstein, MD, MS, Senior Vice President and Chief Medical Officer, Medco Health Solutions and President, United BioSource Corporation

    Wed., June 27, 10:00 - 11:30 a.m.

    SESSION CHAIR AND SPEAKER
    Natural History Studies for Rare Diseases and Orphan Conditions
    Annette Stemhagen, DrPH, FISPE, Senior Vice President, Safety, Epidemiology, Registries and Risk Management, United BioSource Corporation

    Wed., June 27, 1:30 - 3:00 p.m.

    SESSION CHAIR
    Data Sources for Monitoring Usage of Drug Products and How to Use these Sources to Support Safety and REMS Evaluations
    Juliane Mills, Project Manager, SERRM, United BioSource Corporation

  • 9th Annual Meeting HTAi Bilbao 2012

    Jun 25 - Jun 27 2012
    Bilbao, Spain
    www.htai2012.org/


    PANEL SESSION
    How to Optimally Assess the Relative Value of Disease Modifying Treatments in Multiple Sclerosis
    Panel Coordinator: J. Jaime Caro, MDCM, FRCPC, FACP, Senior Vice President, Research, United BioSource Corporation

    ORAL PRESENTATION
    Innovation, Innovation Everywhere - What is Innovation?
    Floortje van Nooten, MSc, PharmD, Research Scientist, United BioSource Corporation; J. Jaime Caro, MDCM, FRCPC, FACP, Senior Vice President, Research, United BioSource Corporation